HT
CLOV icon

HAP Trading’s Clover Health Investments CLOV Stock Holding History

HAP Trading’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,300
Closed -$15.4K – 731
2024
Q4 		$15.4K Sell
16,300
-2,700
-14% -$9.65K ﹤0.01% 591
2024
Q3 		$14.3K Buy
19,000
+6,500
+52% +$14.9K ﹤0.01% 580
2024
Q2 		$2.73K Buy
+12,500
New +$11.2K ﹤0.01% 617
2024
Q1 		– Sell
-51,900
Closed -$281 – 771
2023
Q4 		$281 Buy
51,900
+18,700
+56% +$18.4K ﹤0.01% 901
2023
Q3 		$1.97K Sell
33,200
-11,000
-25% -$13.1K ﹤0.01% 947
2023
Q2 		$3.04K Sell
44,200
-17,500
-28% -$15.5K ﹤0.01% 971
2023
Q1 		$4K Sell
61,700
-164,200
-73% -$180K ﹤0.01% 1012
2022
Q4 		$3K Buy
225,900
+15,300
+7% +$20.4K ﹤0.01% 1301
2022
Q3 		$9K Buy
210,600
+3,300
+2% +$8.64K ﹤0.01% 1345
2022
Q2 		$15K Sell
207,300
-15,900
-7% -$42.3K ﹤0.01% 1387
2022
Q1 		$92K Sell
223,200
-66,100
-23% -$192K ﹤0.01% 1079
2021
Q4 		$87K Buy
289,300
+84,000
+41% +$515K ﹤0.01% 1274
2021
Q3 		$117K Buy
205,300
+14,200
+7% +$121K ﹤0.01% 1213
2021
Q2 		$670K Buy
191,100
+45,300
+31% +$445K 0.02% 563
2021
Q1 		$38K Buy
145,800
+70,900
+95% +$800K ﹤0.01% 1240
2020
Q4 		$352K Buy
+74,900
New +$834K 0.01% 748

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

HAP Trading's CLOV Position: Q4 2022 in Review

HAP Trading sold out of Clover Health Investments (CLOV) in Q4 2022, closing a stake of 138,733 shares — an estimated $185K sold.

HAP Trading first reported a position in CLOV in Q4 2020 and held it in 2 quarters. The position peaked at $512K in Q4 2020. 175 funds tracked by Wall St. Rank hold CLOV as of Q4 2022.

  • HAP Trading reported no remaining Clover Health Investments position as of Q4 2022 after selling out during the quarter.
  • HAP Trading sold 138,733 Clover Health Investments shares in Q4 2022, an estimated $185K.
  • HAP Trading first reported a position in Clover Health Investments in Q4 2020 and held it in 2 quarters.
  • HAP Trading's Clover Health Investments position peaked at $512K in Q4 2020.
  • 175 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2022.

Based on HAP Trading's 13F filing for Q4 2022, filed 14 Feb 2023.